Lisata Therapeutics, Inc. (LSTA) Operating cash flow 2015–2024
Lisata Therapeutics, Inc. (LSTA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$15.9MFY2024 · since FY2015: -$23.7M → -$15.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$15.9M | +17.6% |
| FY2023 | -$19.4M | +3.4% |
| FY2022 | -$20.0M | +5.4% |
| FY2021 | -$21.2M | +4.8% |
| FY2020 | -$22.2M | -152.1% |
| FY2019 | -$8.8M | +53.3% |
| FY2018 | -$18.9M | +5.5% |
| FY2017 | -$20.0M | +4.3% |
| FY2016 | -$20.9M | +11.8% |
| FY2015 | -$23.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LSTA financial trends
LSTA RevenueLSTA Net incomeLSTA Net marginLSTA Gross profitLSTA Gross marginLSTA Operating incomeLSTA Operating marginLSTA Free cash flowLSTA Capital expendituresLSTA Return on equityLSTA Stock buybacksLSTA Dividends paidLSTA Total assetsLSTA Total liabilitiesLSTA Shareholders’ equityLSTA overview →